London, United Kingdom

Diljeet Singh Athwal



 

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 2,324(Granted Patents)


Location History:

  • Slough, GB (2007 - 2018)
  • London, GB (1999 - 2021)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: **Diljeet Singh Athwal: Innovator in Humanised Antibody Technology**

Introduction

Diljeet Singh Athwal is a renowned inventor based in London, GB, with an impressive portfolio of 21 patents. His work primarily focuses on advanced biotechnological innovations, particularly in the field of humanized antibodies. Athwal's inventions have the potential to impact the realms of therapy and diagnostics significantly.

Latest Patents

Athwal's latest patents delve into the creation of humanized antibodies through the development of CDR-grafted antibody heavy and light chains. These patents describe the intricate details of the antibody frameworks, outlining how the heavy chains contain donor residues at specific positions, which enhance their functionality. The CDR-grafted antibodies made from non-human donor frameworks and human acceptor frameworks are preferred for in vivo applications, focusing on therapy and diagnosis. A comprehensive protocol is disclosed in his patents for acquiring these innovative CDR-grafted antibodies, which promises to streamline the process of antibody development.

Career Highlights

Throughout his career, Diljeet Singh Athwal has made significant contributions to biopharmaceutical research and development. He has been associated with Celltech R&D Limited and Celltech Therapeutics Limited, where he has played a pivotal role in advancing biotechnological products through his inventive insights. His expertise in the field of antibody engineering has been widely recognized and has established him as a thought leader in the industry.

Collaborations

Athwal has collaborated with notable professionals like John Spencer Emtage and John Robert Adair, with whom he has shared ideas and worked on groundbreaking projects. These collaborations have contributed to the successful development and patenting of novel biotherapeutics, showcasing the power of teamwork in driving innovation.

Conclusion

Diljeet Singh Athwal's contribution to the field of humanized antibodies demonstrates his commitment to advancing medical science through innovative solutions. With his extensive patent portfolio and collaborative efforts, he continues to influence the future of biopharmaceuticals. His work not only showcases the importance of innovation in healthcare but also highlights the role of inventors in enhancing therapeutic modalities for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…